Codorus Valley Bancorp (NASDAQ:CVLY) reported quarterly earnings of $0.83 per share. This is a 196.43 percent increase over earnings of $0.28 per share from the same period last year.
Harmony Biosciences Announces Topline Results From Phase 2 Proof-of-concept Study Evaluating Pitolisant For Excessive Daytime Sleepiness In Patients With Prader-Willii Syndrome
Harmony Biosciences Holdings, Inc. ("Harmony") (NASDAQ:HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today
